Financials
Financial year 2025
Dr. Peter Vandergoten, Cardiologie from Overijse, company number BE0806516297, closed financial year 2025 with a result of € 456,939 after tax. For that financial year Dr. Peter Vandergoten, Cardiologie recorded a gross margin of € 699,136 and equity of € 3 million. Compared with financial year 2024, the result moved from € 638,419 to € 456,939. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 10, 2026.
€ 3 million
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 456,939
▼ 28% vs 2024
Profit after tax over the fiscal year.
€ 238,182
▼ 52% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 346,051 paid out
76 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 102,186
▼ 24% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 12,009
▲ 23% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,515
▼ 96% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 580,641 | € 670,889 | € 724,278 | € 699,136 | ▼ 3% |
| Profit after taxes | € 385,598 | € 421,131 | € 638,419 | € 456,939 | ▼ 28% |
| Equity | € 2,360,800 | € 2,436,996 | € 2,937,537 | € 3,048,426 | ▲ 4% |
| Total debts | € 42,631 | € 131,461 | € 149,655 | € 31,028 | ▼ 79% |
| Cash | € 812,124 | € 754,911 | € 498,189 | € 238,182 | ▼ 52% |
| Land & buildings | € 340,935 | € 331,549 | € 322,163 | € 312,777 | ▼ 3% |
| Retained profit | € 2,348,400 | € 2,424,596 | € 2,925,137 | € 3,036,026 | ▲ 4% |
| Dividend | € 170,909 | € 344,935 | € 137,877 | € 346,051 | ▲ 151% |
| Balance sheet total | € 2,403,430 | € 2,568,456 | € 3,087,193 | € 3,079,454 |
By gross margin, Dr. Peter Vandergoten, Cardiologie ranks 1st of 4 companies with main activity “Activiteiten op het gebied van voeding” in Overijse that publish figures (fiscal year 2025).
Key figures of Dr. Peter Vandergoten, Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about Dr. Peter Vandergoten, Cardiologie the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr. Peter Vandergoten, Cardiologie?
What happened at Dr. Peter Vandergoten, Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 456,939 (▼ 28% vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- PETER VANDERGOTEN became a director. NBB
In short
From € 385,598 profit in 2022 to € 456,939 profit in 2025.
Paid € 883,623 in corporate taxes since 2022.
Best year ever: 2024, with € 638,419 profit.
Paid out € 999,772 in dividends to the owners in total.
Management
Behind Dr. Peter Vandergoten, Cardiologie is PETER VANDERGOTEN.
Directors
According to the 2025 annual accounts
PETER VANDERGOTEN
Director
since 2008
Establishments
Establishment units
Physical locations of this company
Stobbaertsdreef 5
3090 Overijse
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Overijse
Same main activity (Activiteiten op het gebied van voeding), 4 active companies in Overijse, largest first.
€ 196,538 gross margin · 2025
€ 54,226 gross margin · 2025
€ 23,359 gross margin · 2025
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- Peter VANDERGOTEN(oprichter) 100%
Details
- Company number
- 0806.516.297
- VAT number
- BE 0806.516.297
- Registered office
- Stobbaertsdreef 5, 3090 Overijse
- Names & denominations
- Dr. Peter Vandergoten, Cardiologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 23 September 2008
- Peppol
- Active · Active since 16 Feb 2025
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.